| Importance of paraoxonase 1 (PON1) as an antioxidant and antiatherogenic enzyme in the cardiovascular complications of type 2 diabetes: Genotypic and phenotypic evaluation Y Shokri, A Variji, M Nosrati, A Khonakdar-Tarsi, A Kianmehr, Z Kashi, ... Diabetes research and clinical practice 161, 108067, 2020 | 79 | 2020 |
| The role of metformin response in lipid metabolism in patients with recent-onset type 2 diabetes: HbA1c level as a criterion for designating patients as responders or … Z Kashi, A Mahrooz, A Kianmehr, A Alizadeh PloS one 11 (3), e0151543, 2016 | 47 | 2016 |
| The complex combination of COVID-19 and diabetes: pleiotropic changes in glucose metabolism A Mahrooz, G Muscogiuri, R Buzzetti, E Maddaloni Endocrine 72, 317-325, 2021 | 46 | 2021 |
| Impact of ATM and SLC22A1 polymorphisms on therapeutic response to metformin in Iranian diabetic patients F Shokri, H Ghaedi, SG Fard, A Movafagh, S Abediankenari, A Mahrooz, ... International journal of molecular and cellular medicine 5 (1), 1, 2016 | 46 | 2016 |
| The epigenetic regulation of paraoxonase 1 (PON1) as an important enzyme in HDL function: The missing link between environmental and genetic regulation A Mahrooz, M Mackness, A Bagheri, M Ghaffari-Cherati, P Masoumi Clinical biochemistry 73, 1-10, 2019 | 45 | 2019 |
| The role of clinical response to metformin in patients newly diagnosed with type 2 diabetes: a monotherapy study A Mahrooz, H Parsanasab, MB Hashemi-Soteh, Z Kashi, A Bahar, ... Clinical and experimental medicine 15, 159-165, 2015 | 44 | 2015 |
| The combined utility of myeloperoxidase (MPO) and paraoxonase 1 (PON1) as two important HDL-associated enzymes in coronary artery disease: which has a stronger predictive role? A Variji, Y Shokri, S Fallahpour, M Zargari, B Bagheri, S Abediankenari, ... Atherosclerosis 280, 7-13, 2019 | 38 | 2019 |
| The variant organic cation transporter 2 (OCT2)–T201M contribute to changes in insulin resistance in patients with type 2 diabetes treated with metformin Z Kashi, P Masoumi, A Mahrooz, MB Hashemi-Soteh, A Bahar, A Alizadeh Diabetes Research and Clinical Practice 108 (1), 78-83, 2015 | 32 | 2015 |
| R-carrying genotypes of serum paraoxonase (PON1) 192 polymorphism and higher activity ratio are related to susceptibility against ischemic stroke A Mahrooz, G Gohari, MB Hashemi, M Zargari, H Musavi, M Abedini, ... Molecular biology reports 39, 11177-11185, 2012 | 26 | 2012 |
| Functional mechanisms of miR‐192 family in cancer MA Mishan, MAK Tabari, J Parnian, J Fallahi, A Mahrooz, A Bagheri Genes, Chromosomes and Cancer 59 (12), 722-735, 2020 | 24 | 2020 |
| Increased oxidized-LDL levels and arylesterase activity/HDL ratio in ESRD patients treated with hemodialysis A Mahrooz, M Zargari, O Sedighi, H Shaygani, G Gohari Clinical and Investigative Medicine 35 (3), E144-E151, 2012 | 24 | 2012 |
| Pharmacological interactions of paraoxonase 1 (PON1): a HDL-bound antiatherogenic enzyme A Mahrooz Current Clinical Pharmacology 11 (4), 259-264, 2016 | 23 | 2016 |
| The salt stimulation property of serum paraoxonase (PON1) could be a valuable factor in evaluating the enzyme status in ischemic stroke: the role of activity-determined PON1 … A Mahrooz, A Alizadeh, G Gohari Journal of the neurological sciences 338 (1-2), 197-202, 2014 | 21 | 2014 |
| The polymorphic variants rs3088442 and rs2292334 in the organic cation transporter 3 (OCT3) gene and susceptibility against Type 2 diabetes: Role of their interaction A Mahrooz, A Alizadeh, MB Hashemi-Soteh, M Ghaffari-Cherati, ... Archives of Medical Research 48 (2), 162-168, 2017 | 19 | 2017 |
| The common variant Q192R at the paraoxonase 1 (PON1) gene and its activity are responsible for a portion of the altered antioxidant status in type 2 diabetes PM Mehryar Zargari, Fahimeh Sharafeddin, Abdolkarim Mahrooz, Ahad Alizadeh Exp Biol Med, 1-8, 2016 | 19* | 2016 |
| Naringenin is an inhibitor of human serum paraoxonase (PON1): an in vitro study A Mahrooz, MR Rashidi, M Nouri Journal of Clinical Laboratory Analysis 25 (6), 395-401, 2011 | 18 | 2011 |
| Paraoxonase 1 (PON1)-L55M among common variants in the coding region of the paraoxonase gene family may contribute to the glycemic control in type 2 diabetes A Mahrooz, MB Hashemi-Soteh, M Heydari, R Boorank, F Ramazani, ... Clinica Chimica Acta 484, 40-46, 2018 | 16 | 2018 |
| Protective effect of curcumin on the superoxide dismutase and catalase activity in kidney of acetaminophen-exposed rats M Zargari, S Ahmadi, S Shabani, A Mahrooz Journal of Mazandaran University of Medical Sciences 22 (2), 74-83, 2013 | 15 | 2013 |
| Paraoxonase-2 variants potentially influence insulin resistance, beta-cell function, and their interrelationships with alanine aminotransferase in type 2 diabetes D Qujeq, A Mahrooz, A Alizadeh, R Boorank Journal of Research in Medical Sciences 23 (1), 107, 2018 | 14 | 2018 |
| Association between the synonymous variant organic cation transporter 3 (OCT3)-1233G> A and the glycemic response following metformin therapy in patients with type 2 diabetes SR Hosseyni-Talei, A Mahrooz, MB Hashemi-Soteh, M Ghaffari-Cherati, ... Iranian journal of basic medical sciences 20 (3), 250, 2017 | 14 | 2017 |
